Intrahepatic STAT-3 activation and acute phase gene expression predict outcome after CLP sepsis in the rat.

Interleukin-6 (IL-6) regulates hepatic acute phase responses by activating the transcription factor signal transducer and activator of transcription (STAT)-3. IL-6 also may modulate septic pathophysiology. We hypothesize that 1) STAT-3 activation and transcription of α2-macroglobulin (A2M) correlate with recovery from sepsis and 2) STAT-3 activation and A2M transcription reflect intrahepatic and not serum IL-6. Nonlethal sepsis was induced in rats by single puncture cecal ligation and puncture (CLP) and lethal sepsis via double-puncture CLP. STAT-3 activation and A2M transcription were detected at 3-72 h and intrahepatic IL-6 at 24-72 h following single-puncture CLP. All were detected only at 3-16 h following double-puncture CLP and at lower levels than following single-puncture CLP. Loss of serum and intrahepatic IL-6 activity after double-puncture CLP correlated with mortality. Neither intrahepatic nor serum IL-6 levels correlated with intrahepatic IL-6 activity. STAT-3 activation following single-puncture CLP inversely correlated with altered transcription of gluconeogenic, ketogenic, and ureagenic genes. IL-6 may have both beneficial and detrimental effects in sepsis. Fulminant sepsis may decrease the ability of hepatocytes to respond to IL-6.

[1]  C. Deutschman,et al.  Sepsis-induced depression of rat glucose-6-phosphatase gene expression and activity. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.

[2]  E. Shiloni,et al.  Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels. , 1997, The American journal of physiology.

[3]  R. Piekorz,et al.  Members of the family of IL-6-type cytokines activate Stat5a in various cell types. , 1997, Biochemical and biophysical research communications.

[4]  J. Darnell,et al.  The state of the STATs: recent developments in the study of signal transduction to the nucleus. , 1997, Current opinion in cell biology.

[5]  C. Deutschman,et al.  ALTERED HEPATIC GENE EXPRESSION IN FECAL PERITONITIS: CHANGES IN TRANSCRIPTION OF GLUCONEOGENIC, β‐OXIDATIVE, AND UREAGENIC GENES , 1997, Shock.

[6]  J. Peschon,et al.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Deutschman,et al.  Acute-phase gene expression correlates with intrahepatic tumor necrosis factor-alpha abundance but not with plasma tumor necrosis factor concentrations during sepsis/systemic inflammatory response syndrome in the rat. , 1996, Critical care medicine.

[8]  E. Furth,et al.  Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice , 1996, Science.

[9]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[10]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[11]  A. Sauaia,et al.  The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure , 1996 .

[12]  T. Standiford,et al.  Balance of inflammatory cytokines related to severity and mortality of murine sepsis , 1996, Infection and immunity.

[13]  C. Deutschman,et al.  Increased expression of cytokine-induced neutrophil chemoattractant in septic rat liver , 1996 .

[14]  J. Christman,et al.  Sepsis and cytokines: current status. , 1996, British journal of anaesthesia.

[15]  Jens Schneider-Mergener,et al.  Differential Activation of Acute Phase Response Factor/STAT3 and STAT1 via the Cytoplasmic Domain of the Interleukin 6 Signal Transducer gp130 , 1996, The Journal of Biological Chemistry.

[16]  I. Chaudry,et al.  Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. , 1996, The American journal of physiology.

[17]  G. Regel,et al.  Pattern of Organ Failure following Severe Trauma , 1996, World Journal of Surgery.

[18]  Dongxiao Zhang,et al.  STAT3 Participates in Transcriptional Activation of the C-reactive Protein Gene by Interleukin-6 (*) , 1996, The Journal of Biological Chemistry.

[19]  T. Yen,et al.  Perioperative plasma concentrations of tumor necrosis factor-alpha and interleukin-6 in infected patients. , 1996, Critical care medicine.

[20]  C. Deutschman,et al.  Increased expression of cytokine-induced neutrophil chemoattractant in septic rat liver. , 1995, The American journal of physiology.

[21]  J. Darnell,et al.  Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.

[22]  J. Sjölin,et al.  Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. , 1995, The Journal of infectious diseases.

[23]  J. Christman,et al.  Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. , 1995, Critical care medicine.

[24]  P. Heinrich,et al.  Inhibition by recombinant human interleukin‐6 of the glucagon‐dependent induction of phosphoenolpyruvate carboxykinase and of the insulin‐dependent induction of glucokinase gene expression in cultured rat hepatocytes: Regulation of gene transcription and messenger RNA degradation , 1994, Hepatology.

[25]  M. Brennan,et al.  Systemic and liver cytokine activation. Implications for liver regeneration and posthepatectomy endotoxemia and sepsis. , 1994, Archives of surgery.

[26]  J. Gauldie,et al.  The acute phase response. , 1994, Immunology today.

[27]  F. Cerra,et al.  Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. , 1994, JAMA.

[28]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[29]  E. Deitch,et al.  Multiple organ failure. Pathophysiology and potential future therapy. , 1992, Annals of surgery.

[30]  P Franchimont,et al.  Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. , 1992, Annals of surgery.

[31]  B. Hazenberg,et al.  Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute‐phase proteins during the treatment of severe sepsis in humans , 1992, Critical care medicine.

[32]  I. Chaudry,et al.  Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. , 1983, Surgery.

[33]  I. Chaudry,et al.  Sepsis and septic shock--a review of laboratory models and a proposal. , 1980, The Journal of surgical research.

[34]  M. Pinsky.  Clinical studies on cytokines in sepsis: role of serum cytokines in the development of multiple-systems organ failure. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.